Current Studies
COMMANDER
(Active/Open for Enrollment)
A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects with Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure.
Principal Investigator: Maged Azer, MD
Co-Investigator: Lawrence Santora, MD
Sponsor: Janssen Research & Development
Ovation Prime
(Follow up/Closed for Enrollment)
A PMA Post-Approval Study to Evaluate the Long-Term Safety and effectiveness of the Ovation™/Ovation Prime™ Abdominal Stent Graft System.
Principal Investigator: Preston Flanigan, MD
Co-Investigator: Jeffrey Lawrence Ballard, MD
Co-Investigator: Stacey Tien, PA-C
Sponsor: Endologix
The LUCY Study
(Follow up/Closed for Enrollment)
TriVascular Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair.
Principal Investigator: Preston Flanigan, MD
Co-Investigator: Jeffrey Lawrence Ballard, MD
Co-Investigator: Stacey Tien, PA-C
Sponsor: Endologix
OLYMPUS
(Follow up/Closed for Enrollment)
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients not on Dialysis.
Principal Investigator: Charles J. Kaupke , MD
Co-Investigator: Amer Jabara, MD
Sponsor: AstraZeneca
ROCKIES
(Active/Open for Enrollment)
A Phase 3, Multicenter, Randomized, Open-Label, Active-Controlled Study of Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients.
Principal Investigator: Charles J. Kaupke, MD
Co-Investigator: Amer Jabara, MD
Sponsor: AstraZeneca
CREDENCE
(Follow up/Closed for Enrollment)
A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy.
Principal Investigator: Charles J. Kaupke, MD
Co-Investigator: Amer Jabara, MD
Sponsor: Janssen Research & Development
Grifols GTI 1302
(Follow up/Closed for Enrollment)
A Multicenter, Randomized, Partial-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects with New-Onset Type 1 Diabetes Mellitus.
Principal Investigator: Ivy-Joan Madu, MD
Co-Investigator: Samuel O. Mayeda, MD
Sponsor: Grifols Therapeutics Inc